The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes

Clinical Immunology

Volumn 96, Issue 1, 2000, Pages 11-18

  Bonnevie Nielsen, Vagn ^a   Martensen, Pia M ^b   Justesen, Just ^b   Kyvik, Kirsten O ^a   Kristensen, Bodil ^a   Levin, Klaus ^c   Beck Nielsen, Henning ^c   Worsaa, Anne ^d   Dyrberg, Thomas ^d  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d NOVO NORDISK A S   (Denmark)

Author keywords

2',5' oligoadenylate synthetase; Innate immunity; RNA; Type 1 diabetes; Virus

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; PROTEIN KINASE; RNA;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033948759     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4874     Document Type: Article

References (58)

1. Field L. L., Tobias R. Unravelling a complex trait: The genetics of insulin-dependent diabetes mellitus. Clin. Invest. Med. 20:1997;41-49.
2. Petersen J. S., Kyvik K. O., Bingley P. J., Gale E. A., Green A., Dyrberg T., Beck-Nielsen H. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus. Br. Med. J. 314:1997;1575-1579.
3. Dyrberg T., MacKay P., Michelsen B., Petersen J. S., Karlsen A. E., Bonnevie-Nielsen V. Viruses in diabetes mellitus. Friedman H., Rose N., Bendinelli M. Microorganisms and Autoimmune Diseases. 1995;105-127 Plenum, New York.
4. Graves P. M., Norris J. M., Pallansch M. A., Gerling I. C., Rewers M. The role of enterovirus infections in the development of IDDM. Diabetes. 46:1997;161-168.
5. Dahlquist G., Ivarsson S., Lindberg B., Forsgreen M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. Diabetes. 44:1995;408-413.
6. Hiltunen M., Hyöty H., Knip M., Ilonen J., Reijonen H., Vähäsalo P., Roivainen M., Lönnrot M., Leinikki P., Hovi T., Åkerblom H. K. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. J. Infect. Dis. 175:1997;554-560.
7. Foulis A. K., McGill M., Farquharson M. A., Hilton D. A. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia. 40:1997;53-61.
8. Buesa-Gomez J., Carlos de la Torre J., Dyrberg T., Landin-Olsson M., Mauseth R. S., Lernmark Å., Oldstone M. B. A. Failure to detect genomic viral sequences in pancreatic tissues from two children with acute-onset diabetes mellitus. J. Med. Virol. 42:1994;193-197.
9. Conrad B., Weismahr R. N., Boni J., Arcari R., Schupbach J., Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type 1 diabetes. Cell. 90:1997;303-313.
10. Muir A., Ruan Q. G., Marron M. P., She J. X. The IDDMK (1, 2) 22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes. 48:1999;219-222.
11. Badenhoop K., Donner H., Neumann J., Hervig J., Kurth R., Usadel K. H., Tonje R. R. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes. 48:1999;215-218.
12. Fearon D. T., Locksley R. M. Elements of immunity - The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-54.
13. Bachmann M. F., Zinkernagel R. M., Oxenius A. Immune responses in the absence of costimulation: Viruses know the trick. J. Immunol. 161:1998;5791-5794.
14. Biron C. Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:1998;383-390.
15. von Herrath M. G., Holz A., Homann D., Oldstone M. B. Role of viruses in type 1 diabetes. Semin. Immunol. 10:1998;87-100.
16. Tough D. F., Sprent J. Viruses and T-cell turnover: Evidence for bystander proliferation. Immunol. Rev. 150:1996;129-142.
17. Horwitz M. S., Bradley L. M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry. Nat. Med. 4:1998;781-785.
18. Singh B., Prange S., Jevnikar A. M. Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus. Semin. Immunol. 10:1998;79-86.
19. Lorber B. Are all diseases infectious? Ann. Int. Med. 125:1996;844-851.
20. Sen G. C., Ransohof R. M. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:1993;57-102.
21. Chakrabarti D., Hultgren B., Stewart T. A. IFN-α induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7. J. Immunol. 157:1996;522-528.
22. Taniguchi T. Tanaka, Taki, S. Eur. Cytokine Netw. 9:1998;43-48.
23. Demotz S., Grey H. M., Settle A. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science. 249:1990;1028-1030.
24. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:1999;821-829.
25. Clemens M. J., Elia A. The double-stranded RNA-dependent protein kinase PKR: Structure and function. J. Interferon Res. 17:1997;503-524.
26. Hartmann R., Nørby P. I., Martensen P. M., Jørgensen P., James M. C., Jacobsen C., Moestrup S. K., Clemens M. J., Justesen J. Activation of 2′-5′ oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers. J. Biol. Chem. 273:1998;3236-3246.
27. Ponten A., Sick C. H., Weber M., Haller O., Kochs G. Dominant negative mutants of human MxA protein: Domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J. Virol. 71:1997;2591-2599.
28. Bonnevie-Nielsen V., Heron I., Kristensen T., Michelsen B., Lernmark Å. Association of IDDM and attenuated response of 2′,5′-oligoadenylate synthetase to yellow fever vaccine. Diabetes. 38:1989;1636-1642.
29. Justesen J., Ferbus D., Thang M. N. Elongation mechanism and substrate specificity of 2′,5′-oligoadenylate synthetase. Proc. Natl. Acad. Sci. USA. 77:1980;4618-4622.
30. Langland J. O., Pettiford S. M., Jacobs B. L. Nucleic acid affinity chromatography. Protein Expr. Purif. 6:1995;25-32.
31. Gerdes A. M., Hørder M., Bonnevie-Nielsen V. Genedosage and downregulation of the α-interferon receptor. Scand. J. Clin. Lab. Invest. 52:1992;189-192.
32. Cahill, G. F., and McDevitt, H. O., Insulin-dependent diabetes mellitus: The initial lesion. N. Engl. J. Med.304, 1454-1465, 1981.
33. McDevitt H. O. The role of MHC class II molecules in susceptibility and resistance to autoimmunity. Curr. Opin. Immunol. 10:1998;677-681.
34. Schranz D. B., Lernmark Å. Immunology in diabetes: An update. Diabetes Metab. 14:1998;3-29.
35. Tisch R., McDewitt H. Insulin-dependent diabetes mellitus. Cell. 85:1996;291-297.
36. Larger E., Becourt C., Bach J. F., Boitard C. Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model. J. Exp. Med. 181:1995;1635-1642.
37. Katz J. D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 268:1995;1185-1188.
38. Kolb H., Worz-Pagenstert U., Kleemann R., Rothe H., Rowsell P., Rastegar S., Scott F. W. Insulin therapy of prediabetes suppresses TH1 associated gene expression in BB rat pancreas. Autoimmunity. 26:1997;1-6.
39. Lindberg L., Ivarsson S. A., Landin-Olsson M., Svanberg L., Lernmark Å. Islet autoantibodies in cord blood from children who developed type 1 (insulin-dependent) diabetes mellitus before 15 years of age. Diabetologia. 42:1999;181-187.
40. Redondo M. J., Rewers M., Yu L., Garg S., Pilcher C. C., Elliott R. B., Eisenbarth C. S. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. Br. Med. J. 318:1993;698-702.
41. Rice A. P., Duncan R., Hershey J. W. B., Kerr I. M. Double-stranded RNA-dependent protein kinase and the 2-5 A system are both activated in interferon treated, encephalomyocarditis virus-infected HeLa cells. J. Virol. 54:1985;894-898.
42. Pfeffer L. M., Dinarello C. A., Herberman R. B., Williams B. R. G., Borden E. C., Bordens R., Walter M. R., Nagabhushan T. L., Trotta P. P., Pestka S. Biological properties of recombinant interferon: 40th anniversary of the Discovery of interferons. Cancer Res. 58:1998;2489-2499.
43. Gribaudo G. D., Lembo D., Cavello G., Landolfo S., Lengyel P. Interferon action: Binding of viral RNA to the 40-kilodalton 2′,5′ oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J. Virol. 65:1991;1748-1757.
44. Sugin H., Mitani I., Koike M., Kodama T., Sokawa J., Sawai H., Ishibashi K., Itoh M., Watanabe S., Sokawa Y. Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases. J. Clin. Microbiol. 24:1986;478-481.
45. Buffet-Janvresse C., Magard H., Robert N., Hovanessian A. G. Assay and the levels of 2′-5′ A-synthetase in lymphocytes of patients with viral, bacterial and autoimmune diseases. Ann. Immunol. (Inst. Pasteur). 134 D:1983;247-258.
46. Bonnevie-Nielsen V., Heron I., Monath T. P., Calisher C. Lymphocytic 2′,5′-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin. Diagn. Lab. Immun. 2:1995;302-306.
47. Maitra R. K., McMillan N. A. J., Desai S., McSwiggen J., Hovanessian A. G., Sen G., Williams B. R. G., Silverman R. H. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology. 204:1994;823-827.
48. Desai S. Y., Patel R. C., Sen G. C., Malhotra P., Ghadge G. D., Thimmapaya B. Activation of interferon-inducible 2′-5′ oligoadenylate synthetase by adenoviral VAI RNA. J. Biol. Chem. 270:1995;3454-3461.
49. Samuel C. E. Antiviral actions of interferon. Virology. 183:1991;1-11.
50. Der S. D., Lau A. S. Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc. Natl. Acad. Sci. USA. 92:1995;8841-8845.
51. 1. RNA. 2:1996;937-955.
52. Clarke P. A., Sharp N. A., Arrand J. R., Clemens M. J. Epstein-Barr virus gene expression in interferon-treated cells. Biochim. Biophys. Acta. 1050:1990;167-173.
53. Brand S. R., Kobayashi R., Matthews M. B. The TAT protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-α induced, virally activated proteinkinase, PKR. J. Biol. Chem. 27:1997;8388-8395.
54. Hitman G. A., Toms G. C., Boucher B. J., Baker P., Awad J., Festenstein H. 2′,5′ oligoadenylate synthetase and its relationship to HLA and genetic markers of insulin-dependent diabetes melitus. Immunogenetics. 30:1989;427-431.
55. Huppertz H-I., Becker K., Kreth H. W. Clinical value of measuring the interferon-induced enzyme 2′-5′-oligoadenylate synthetase in children. Acta Paediatr. 81:1992;329-334.
56. Buffet-Janvresse C., Vannier J. P., Laurent A. G., Robert N., Hovanessian A. G. Enhanced level of double-stranded RNA-dependent protein kinase in peripheral blood mononuclear cells of patients with viral infections. J. Interferon Res. 6:1986;85-96.
57. Galabru J., Katze M. G., Robert N., Hovanessian A. G. The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur. J. Biochem. 69:1989;581-589.
58. Huang X., Yuan J., Goddard A., Foulis A., James R. F. L., Lernmark Å., Pujol Borell R., Rabinowitch A., Somoza N., Stewart T. Interferon expression in the pancreases of patients with type 1 diabetes. Diabetes. 44:1995;658-664.